Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter 'Shionogi' ) has announced that Shionogi has gained A- rating for 'Climate Change' and chosen as an A-List Company, the highest evaluation, for 'Water security', in the surveys conducted by CDP1 , a global not-for-profit organization working on environmental information disclosure.

Shionogi idenfied 'Protect the Environment' as an material issue to be addressed and set action targets based on the 'Shionogi Group EHS2 Policy' to contribute to environmental protection. In particular, we focus on climate change, water risk, and AMR3 , and we are developing activities not only in our business activities such as research, development, manufacturing and sales of pharmaceuticals, but also in the cooperating supply chain.

We believe that this survey evaluated our efforts to reduce greenhouse gas emissions, protect the water resources, reduce the risk of flooding, and appropriately manage wastewater to reduce the release of antimicrobials into the natural environment as a part of initiatives of AMR.

Shionogi outlines a vision of 'growing sustainably as a drug discovery-based pharmaceutical company contributing to a more vigorous society through improved healthcare,' and by continuing activities related to 'Protect the Environment,' we will continue to work to become a company that is needed by all of our stakeholders in the future.

Contact:

Tel: +81-6-6209-7885

Forward-Looking Statements

This announcement contains forward-looking statements. These statements are based on expectations in light of the information currently available, assumptions that are subject to risks and uncertainties which could cause actual results to differ materially from these statements. Risks and uncertainties include general domestic and international economic conditions such as general industry and market conditions, and changes of interest rate and currency exchange rate. These risks and uncertainties particularly apply with respect to product-related forward-looking statements. Product risks and uncertainties include, but are not limited to, completion and discontinuation of clinical trials; obtaining regulatory approvals; claims and concerns about product safety and efficacy; technological advances; adverse outcome of important litigation; domestic and foreign healthcare reforms and changes of laws and regulations. Also for existing products, there are manufacturing and marketing risks, which include, but are not limited to, inability to build production capacity to meet demand, unavailability of raw materials and entry of competitive products. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

CDP

CDP is a global non-profit that drives companies and governments to reduce their greenhouse gas emissions, safeguard water resources and protect forests. Voted number one climate research provider by investors and working with institutional investors with assets of US$96 trillion, we leverage investor and buyer power to motivate companies to disclose and manage their environmental impacts. Over 8,400 companies with over 50% of global market capitalization disclosed environmental data through CDP in 2019. This is in addition to the over 920 cities, states and regions who disclosed, making CDP's platform one of the richest sources of information globally on how companies and governments are driving environmental change.

(C) 2020 Electronic News Publishing, source ENP Newswire